Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Jul 1.
Published in final edited form as: Behav Ther. 2024 Oct 24;56(4):723–737. doi: 10.1016/j.beth.2024.10.005

A pilot trial of an LGBTQ-affirmative cognitive-behavioral therapy for transgender and gender expansive individuals’ mental, behavioral, and sexual health

Corina Lelutiu-Weinberger a,*, Mircea L Filimon a,1, Danielle Chiaramonte b, Sarah Leonard a, Bogdan Dogaru c, Elena Pana d, Cristiana Pruneanu e, John E Pachankis b
PMCID: PMC12181672  NIHMSID: NIHMS2032016  PMID: 40541374

Abstract

Transgender and gender expansive (TGE) individuals face minority stress and associated health risks, especially in high-stigma contexts. LGBTQ-affirmative cognitive-behavioral therapy (CBT) is one of the only evidence-based interventions developed to address minority stress to improve psychosocial health. Yet, trials of this treatment have mostly enrolled cisgender sexual minorities, TGE youth, and those living in North American contexts. This study tested the feasibility, acceptability, and preliminary efficacy of LGBTQ-affirmative CBT for TGE adults living in the high-stigma context of Romania. Twenty-five TGE individuals (Mage=25.16, SDage=6.39; 44% transgender women, 40% transgender men, 16% non-binary) reporting depression and/or anxiety symptoms received 16 virtual sessions of LGBTQ-affirmative CBT from trained psychologists. Assessments of mental (e.g., depression), behavioral (e.g., hazardous drinking), and sexual (e.g., HIV-transmission risk behavior) health outcomes, and minority stress and universal risk mechanisms were administered at baseline and 5-month follow-up. Results showed reductions in depression and anxiety symptoms and certain minority stress (e.g., anticipated stigma, identity concealment) and universal risk (e.g., unassertiveness) mechanisms from baseline to follow-up. The intervention was highly feasible (e.g., timely recruitment, high session attendance), and exit interviews revealed high acceptability in terms of the treatment’s relevance, goals, imparting minority stress knowledge and identity-related hope and acceptance, format, and therapeutic alliance. LGBTQ-affirmative CBT shows feasibility, acceptability, and preliminary efficacy among TGE individuals living in Romania, with promise for other high-stigma contexts. Future randomized controlled trials and reductions in structural determinants remain priorities.

Keywords: transgender, mental health, cognitive-behavioral therapy, minority stress, stigma

Introduction

Transgender and gender expansive (e.g., gender non-binary) (TGE) individuals living in contexts lacking legal gender recognition and protections for TGE individuals and few affirmative health resources (Bränström & Pachankis, 2021), experience pronounced health disparities. These disparities include elevated rates of depression, anxiety, (Bouman et al., 2017; Budge et al., 2013), and suicidality (Romanelli et al., 2018) compared to cisgender people, which co-occur with increased behavioral health risks, such as for hazardous drinking (Gonzalez et al., 2017) and HIV infection (Centers for Disease Control and Prevention, 2016; Poteat et al., 2014).

Minority stress theory locates the source of these disparities within TGE people’s exposure to stigma-related stressors (Meyer, 2003; Testa et al., 2015). TGE individuals experience pronounced rates of victimization and sexual assault (James et al., 2016; Reback et al., 2017), which are associated with poor psychosocial health (Valentine & Shipherd, 2018). According to minority stress theory, structural and interpersonal stigma affect TGE individuals’ psychosocial health by generating identity-specific coping tendencies (e.g., anticipated and internalized stigma) and universal risks for adverse mental and behavioral health (e.g., rumination, social isolation) (Staples et al., 2018; Timmins et al., 2017). These tendencies mediate the association between stigma exposure and depression, anxiety (Scandurra et al., 2017), and suicidal ideation (Staples et al., 2018). Initially adaptive coping tendencies can become health-impairing if maintained over time and inflexible to context (Pachankis, Soulliard, et al., 2023). Such health-impairing processes can manifest as both minority stress mechanisms (Meyer, 2003) and more universal mechanisms (Hatzenbuehler, 2009).

Many TGE individuals receive inadequate health care (Stroumsa, 2014), as TGE-specific expertise is rare (Morrison et al., 2017) and few supportive services address the psychosocial impact of minority stress on TGE individuals’ psychosocial health (Budge & Moradi, 2018). As a result, TGE individuals often receive inadequate care (Heng et al., 2018), anticipate mistreatment, and forego care (Glick et al., 2018).

Cognitive-behavioral therapy (CBT) has been adapted to address the role of minority stress in psychosocial health risks faced by stigmatized groups (Pachankis, 2018). LGBTQ-affirmative CBT uses CBT principles and techniques to address the identity-specific and universal stress processes elevating LGBTQ people’s risk of poor psychosocial health outcomes. Recognizing that reactions to minority stress (e.g., internalized stigma, identity concealment) are cognitive, affective, and behavioral in nature, LGBTQ-affirmative CBT uses techniques to modify those responses to be more likely to generate positive psychosocial health (Burger & Pachankis, 2024). Consequently, LGBTQ-affirmative CBT responds to recommendations for providing affirmative psychosocial care to TGE individuals (Chang & Singh, 2018).

Several randomized controlled trials (RCTs) have found that LGBTQ-affirmative CBT yields improvements in psychosocial health (Pachankis, Harkness, Maciejewski, et al., 2022), especially for individuals with high stigma exposure (Keefe et al., 2023). However, several of these trials enrolled both TGE and cisgender individuals, with one of the most rigorous trials including about 40% TGE individuals (Pachankis, McConocha, et al., 2020). Two small, single-arm pilot trials (Austin et al., 2018; Craig & Austin, 2016) have examined LGBTQ-affirmative CBT for TGE individuals, using a group format across two days; however, these studies were limited to TGE youth, who face developmentally distinct challenges (Fontanari et al., 2020). While LGBTQ-affirmative CBT represents a promising treatment for TGE individuals, all existing trials have taken place in North America, hindering generalizability to contexts with greater structural stigma and fewer affirmative supports (Bränström & Pachankis, 2021).

TGE people in contexts like Romania experience few protections and rights, and a lack of affirmative health care. Accurate prevalence data on TGE people in Romania do not exist; however, one survey found the prevalence of TGE people to be 3% among relatively educated, urban, and affluent people living in Romania (Statista, 2024). Among TGE people living in Romania, 63% expressed lifetime suicidal ideation, and 72% have desired, but not received, psychological and/or psychiatric support (Popa et al., 2020). TGE people living in Romania report stark experiences of stigma: no governmental response to safety needs (62% vs. 42% in the European Union overall), always/often avoiding gender expression that is not consistent with sex designated at birth out of fear of assault (41% vs. 30%), and physical/sexual assault due to gender expression (29% vs. 17%) (European Union Agency for Fundamental Rights, 2020).

To respond to the health needs of TGE adults in Romania and other high-stigma contexts, we adapted an existing LGBTQ-affirmative CBT intervention (Pachankis, Harkness, Jackson, et al., 2022; Pachankis, McConocha, et al., 2020) and conducted a one-arm trial to test its feasibility, acceptability, and preliminary efficacy.

Materials and Methods

Intervention adaptation

In September and October 2021, a series of 1-hour remote video focus groups were held with health providers (n=6) and TGE individuals (n=19) in Romania to gather input regarding: (1) TGE experiences in Romania, including gender-affirming care; (2) mental, behavioral, and sexual health concerns and treatment experiences; (3) minority stressors and stigma; (4) the relationship between minority stressors, stigma, and psychosocial health; and (5) ways of coping with stigma. Participants reported a mean age of 26.57 (SD=9.22) and 36% identified as trans women, 57% as trans men, and 7% as genderqueer. Two participants were also community activists who informed the interview guide. Gender affirmation was a primary concern, with participants reporting difficulties finding competent medical providers in Romania, leading them to seek care abroad. Gender-affirming medical procedures were helpful in facilitating stress coping. Some reported using alcohol to cope with minority stress. HIV-transmission risk behavior was low. Minority stress-related mental health concerns (e.g., depression, anxiety), stigma, and gender dysphoria emerged as primary concerns.

Focus groups also elicited intervention adaptation feedback (Pachankis, Soulliard, et al., 2023). LGBTQ-affirmative CBT as tested here represents an adaptation to the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (Barlow et al., 2017; Farchione et al., 2024) through consultation with LGBTQ individuals and expert clinicians to address the adverse impact of minority stress (Pachankis, 2015). The modules raise awareness of the impact of minority stress on health, instill cognitive flexibility, reduce maladaptive avoidance tendencies rooted in minority stress, and are guided by six principles (e.g., normalizing negative mood in response to LGBTQ-related stress) (Pachankis, McConocha, et al., 2020; Pachankis, Soulliard, et al., 2023).

The focus group data were analyzed using thematic analysis (Miles & Huberman, 1994) to identify themes for adapting LGBTQ-affirmative CBT for TGE people. Resulting themes, along with participant quotes, were presented to the study therapists during the intervention training as recommended content to assess and address during the case conceptualization process with each participant. Themes included challenges of passing, isolation, self-harm, internalized stigma, fear of rejection, alienation, distrust of mental health providers, lack of sexual health education, and substance use as a coping mechanism. Suggested adaptations were considered “surface” rather than “deep” as they involved text revisions to language and clinical examples rather than new or deleted modules (Hwang, 2016; Resnicow et al., 1999).

Study procedures for the intervention trial

Recruitment for the trial itself occurred March-June 2022 via advertisements placed on social media by LGBTQ organizations in Romania and via word-of-mouth. The advertisements led participants to an electronic consent form and eligibility screening. Participants had to: (1) be a TGE individual, determined by asking one’s gender identity and sex assigned at birth; (2) be ≥18 years old; (3) report a score of ≥2.5 on either the two items measuring depression or the two measuring anxiety symptoms on the Brief Symptom Inventory (BSI-4) (Lang et al., 2009); and (4) reside in Romania. Exclusion criteria were: (1) elevated suicidal ideation, determined by a score of ≥21 on the Suicidal Ideation Attributes Scale (Van Spijker et al., 2014) and subsequent clinician follow-up to assess the strength of intent, means, and plan, and/or mania or psychosis (assessed continuously during study sessions) and (2) past-12-month receipt of CBT. Two participants were excluded for elevated suicidal ideation. Participants completed online assessments at baseline and five months post-baseline. After the baseline assessment, participants were assigned to one of two study psychologists who delivered up to 16 1-hour individual weekly intervention sessions on Zoom. The 5-month follow-up assessment occurred up to four weeks after session completion. Ten (40%) participants completed an exit interview, led by the principal investigators. Participants received the Romanian equivalent of $30 and $40 for the two assessments, $10 per intervention session, and $30 for exit interviews.

Study psychologist training and fidelity monitoring

Two psychologists delivered the intervention. Both held a Masters degree in clinical psychology, a specialization in CBT, and five years of experience providing care to TGE individuals. They first completed a two-day training conducted by the last author, including a review of the theoretical basis, content, and delivery of the modules. The psychologists practiced delivering all sessions, taking turns role-playing and receiving biweekly remote supervision. At the start of the trial, the supervisor reviewed all session transcripts for the first two participants per psychologist (translated into English). Thereafter, the supervisor selected two sessions per participant (for a total of 25% of study sessions) to verify fidelity. The supervisor specifically rated each session using the LGBTQ-affirmative CBT fidelity assessment used in other trials of LGBTQ-affirmative CBT (e.g., Pachankis et al., 2020). This assessment contains an average of six items per module that capture the core skills and principles to be applied during that module. The supervisor rates the degree of coverage of the components of that module, from 0 (not covered at all) to 2 (covered thoroughly). The average fidelity rating was 1.77 (SD=0.29).

Measures

A certified translator translated the measures into Romanian. There were no missing data. While scales elicited responses based on different timeframes (e.g., past seven or 30 days), the timeframe portion of the prompt for each measure was bolded to increase data accuracy.

Demographics.

Participants completed items assessing age, gender identity, sex assigned at birth, sexual orientation, ethnicity, educational attainment, and HIV status.

Mental and Behavioral Health Outcomes.

Depression symptoms.

Participants completed the 20-item Center for Epidemiological Studies-Depression Scale (CES-D; Radloff, 1977) assessing frequency of past-week depression symptoms (e.g., “I was bothered by things that usually don’t bother me”) from 0 (rarely or none of the time [less than 1 day]) to 3 (most or all of the time [5–7 days]); items were summed. Cronbach’s α was 0.82 at baseline and 0.81 at follow-up. Participants completed the 5-item Overall Depression Severity & Impairment Scale (ODSIS) (Bentley et al., 2014) on past-week frequency, severity, and functional impairment related to depression symptoms (e.g., “In the past week, how much did your depression interfere with your ability to do the things you needed to do at work, at school, or at home?”) measured from 0 (no depression in the past week) to 4 (constant depression: felt depressed all of the time); items were summed. Cronbach’s α was 0.90 at baseline and follow-up.

Anxiety symptoms.

Past-week frequency, severity, and functional impairment related to anxiety symptoms was assessed using the 5-item Overall Anxiety Severity & Impairment Scale (OASIS) (Norman et al., 2006) (e.g., “In the past week, how often have you felt anxious?”), ranging from 0 (no anxiety in the past week) to 4 (constant anxiety: felt anxious all of the time). Items were summed. Cronbach’s α was 0.73 at baseline and 0.77 at follow-up.

Psychological distress.

Psychological distress was assessed using the 18-item Brief Symptom Inventory (BSI-18) (Derogatis & Melisaratos, 1983) consisting of three 6-item subscales ranging from 0 (not at all) to 4 (extremely) of depression symptoms (e.g., “feeling hopeless about the future”), anxiety symptoms (e.g., “feeling tense or keyed up”), and somatization symptoms (e.g., “feeling weak in parts of your body”). Items were summed. Cronbach’s α was 0.88 at baseline and 0.92 at follow-up.

Suicidal ideation.

The Suicidal Ideation Attributes Scale (SIDAS) (Van Spijker et al., 2014) assessed participants’ past-month suicidal thoughts and severity, with response options from 0 (never or not at all) to 10 (always or extremely). Participants who reported no ideation in response to the first item were not presented with subsequent four items regarding the severity of these thoughts and responses were recoded to 0. Items were summed, with a 0–50 range. Cronbach’s α was 0.89 at baseline and 0.82 at follow-up.

Hazardous drinking.

The 3-item Alcohol Use Disorders Identification Test (AUDIT-C; (Bush et al., 1998) captured past year drinking (e.g., “How often, during the past year, did you have a drink containing alcohol?”), with response options between 0 (never) and 4 (four or more times per week). Items were summed. Cronbach’s α was 0.83 at baseline and 0.88 at follow-up.

HIV-transmission risk behavior.

One’s HIV status, pre-exposure prophylaxis (PrEP) use, sex partners, and past 3-month sexual behaviors were assessed. A binary variable of HIV-transmission risk behavior was calculated based on past-3-month condomless anal or vaginal sex with a penis, without self-reported adherent PrEP use (i.e., ≥4 times per week) for participant and HIV-negative primary partner, or undetectable viral load for HIV-positive primary partner.

Minority Stress Mechanisms.

Subscales of the Gender Minority Stress and Resilience Measure (GMSR) (Testa et al., 2015) were used to measure most minority stress mechanisms. Response options ranged from 1 (strongly disagree) to 5 (strongly agree). These subscales are described below.

Anticipated stigma.

The 9-item Negative Expectations for Future Events GMSR subscale (Testa et al., 2015) was used to measure anticipated stigma (e.g., “If I express my gender history, employers would not hire me.”). The items were summed; higher scores indicate fear of rejection based on gender identity. Cronbach’s α was 0.83 at baseline and 0.90 at follow-up.

Internalized stigma.

The 8-item Internalized Transphobia GMSR subscale (Testa et al., 2015) was used to measure internalized stigma (e.g., “I resent my gender identity or expression.”). Items were summed; higher scores indicate higher internalized stigma. Cronbach’s α was 0.90 at baseline and 0.95 at follow-up.

Identity concealment.

The 5-item Non-Disclosure GMSR subscale (Testa et al., 2015) measured identity concealment (e.g., “Because I don’t want others to know my gender history, I modify my way of speaking.”). The items were summed; higher scores indicate increased gender identity concealment. Cronbach’s α was 0.78 at baseline and 0.35 at follow-up.

Pride.

The 8-item Pride GMSR subscale (Testa et al., 2015) was used to measure gender identity pride (e.g., “My gender identity or expression makes me feel special and unique.”) The items were summed; higher scores indicate greater pride in one’s gender identity. Cronbach’s α was 0.78 at baseline and 0.84 at follow-up.

Community connectedness.

The 5-item Community Connectedness GMSR subscale (Testa et al., 2015) assessed TGE community connectedness (e.g., “I feel part of a community of people who share my gender identity.”); items were summed with higher scores indicating greater community connectedness. Cronbach’s α was 0.81 at baseline and 0.72 at follow-up.

Gender identity rumination.

The 15-item Gender Identity Reflection and Rumination Scale (GRRS; (Bauerband & Galupo, 2014) assessed the ways respondents think about their gender identity, with response options from 1 (almost never) to 4 (almost always) (e.g., “Analyze how my experience of my gender identity shapes who I am.”). Items were summed; higher scores indicate more rumination. Cronbach’s α was 0.89 at baseline and 0.81 at follow-up.

Universal mechanisms

Emotion dysregulation.

The 18-item Difficulties in Emotion Regulation Scale—Short Form (DERS-SF) (Gratz & Roemer, 2004; Kaufman et al., 2016) was used to assess frequency of emotion dysregulation, with response options from 1 (almost never) to 5 (almost always) (e.g., “When I’m upset, I acknowledge my emotions.”); items were summed. Cronbach’s α was 0.81 at baseline and 0.90 at follow-up.

Social support.

The 12-item Multidimensional Scale of Perceived Social Support (MSPSS) (Zimet et al., 1990) was used to assess perceived support from family, friends, and significant others, with response options from 0 (very strongly disagree) to 7 (very strongly agree) (e.g., “There is a special person who is around when I am need.”). A mean score was calculated. Cronbach’s α was 0.78 at baseline and 0.86 at follow-up.

Unassertiveness.

The 19-item Simple Rathus Assertiveness Schedule—Short Form (SRAS-SF) (Rathus, 1973) assessed unassertiveness, with response options from 1 (very uncharacteristic of me) to 6 (very characteristic of me) (e.g., “I strive to get ahead as well as most people in my position.”). Seven items were reverse-coded and then summed for a total score where higher scores indicate higher unassertive behavior. Cronbach’s α was 0.66 at baseline and 0.56 at follow-up.

Rumination.

The 5-item Brooding subscale from the Ruminative Responses Scale (RRS) (Treynor et al., 2003) was used to assess frequency of brooding thoughts in response to depressed mood, with response options from 1 (almost never) to 4 (almost always) (e.g., “People think and do many different things when they feel depressed. Please indicate what you generally do. ‘Think what am I doing to deserve this?’”). The items were summed. Cronbach’s α was 0.74 at baseline and 0.70 at follow-up.

Treatment Feasibility and Acceptability

Session attendance served as a partial indicator of intervention feasibility and acceptability. One-hour semi-structured interviews were conducted with a purposive sample of 10 participants selected to achieve gender representation of the intervention sample. Questions assessed intervention feasibility (e.g., videoconferencing) and acceptability (e.g., relevance of treatment content to personal goals, impact on mental health and gender-related experiences). Interviews were transcribed verbatim using a professional transcription service.

Data analysis

Preliminary efficacy analyses

Summary statistics (e.g., means, standard deviations) and graphical summaries (e.g., boxplots, histograms) described variable distributions. For variables with a normal distribution, we conducted paired-sample t-tests to assess change from baseline to 5-month follow-up. For variables with skewed distributions, we used the non-parametric Wilcoxon matched pairs test (Pett, 2015). All results were evaluated at p <0.05 and using Hedges’ g effect sizes (Hedges & Olkin, 1985). To correct for multiple comparisons, we used the Benjamini-Hochberg procedure with a false discovery rate of 0.05 (Benjamini & Hochberg, 1995; Simes, 1986).

Treatment feasibility and acceptability

We calculated average number of sessions attended. For exit interview data, a qualitative data analysis codebook was developed using pre-determined themes; coding began with a deductive thematic analysis approach (Elo & Kyngäs, 2008) using Dedoose (version 9.0.90). Participant-generated content was coded using an inductive coding approach. All authors iteratively refined the codebook, after which two authors double-coded all transcripts.

Results

Figure 1 illustrates participants’ study progression. Table 1 provides participant demographic characteristics at baseline (n=25). Most participants were young adults (M=25.2, SD=6.4), identified as transgender women (44%) or transgender men (40%), and as Romanian (84%). Most (64%) reported difficulty paying for basic needs (e.g., food, housing, medical care).

Figure 1.

Figure 1.

CONSORT diagram.

Table 1.

Demographic characteristics at baseline (n=25).

Age (M, SD) 25.16 (6.39)
N %

Gender identity
 Transgender woman 11 44.0
 Transgender man 10 40.0
 Nonbinary (e.g., genderqueer, agender, gender fluid) 4 16.0
Sex assigned at birth
 Female 13 52.0
 Male 10 40.0
 Intersex 2 8.0
Sexual orientation
 Bisexual 5 20.0
 Demisexual 1 4.0
 Gay 1 4.0
 Heterosexual 8 32.0
 Pansexual 4 16.0
 Queer 6 24.0
Ethnicity
 Romanian 21 84.0
 Roma 1 4.0
 Multi-ethnic and other 3 12.0
Educational attainment
 High school or less 12 48.0
 Some college 4 16.0
 College degree 7 28.0
 Graduate degree 2 8.0

Mental, behavioral, and sexual health outcomes

Results indicate significant improvements in mental health following receipt of LGBTQ-affirmative CBT (Table 2; Figure 2). Reductions in depression and anxiety symptom severity and psychological distress from baseline to follow-up were statistically significant. Effect sizes for depression (g=−0.96) and anxiety severity (g=−1.04) were large, indicating strong change across time. Behavioral health also decreased between baseline and follow-up with hazardous drinking with a small effect (g=−0.35).

Table 2.

Pre- to post-intervention changes in study outcomes.

Baseline (n=25) Follow-up (n=22)
M (SD) M (SD) t-score / Wilcoxon 1 p-value Effect Size (Hedge’s g) Adjusted Statistical Significance2
Mental and Behavioral Health Outcomes
 Psychological Distress 1.46 (0.729) 1.11 (0.745) 3.18 0.004 −0.46
(small)
Sig.
 Depression Symptoms (CES-D) 28.4 (13.6) 25.0 (13.00) 1.19 0.26 −0.26
(small)
 Depression Severity and Impairment1 9.68 (4.96) 4.82 (5.04) 208.5 0.001 −0.96
(large)
Sig.
 Anxiety Severity and Impairment1 10.1 (3.72) 5.05 (4.69) 202.0 0.001 −1.04
(large)
Sig.
 Suicidal Thoughts1 8.00 (10.70) 4.50 (7.97) 78.5 0.11 −0.45
(small)
 Hazardous Drinking1 2.92 (2.25) 2.18 (1.97) 56.0 0.03 −0.35
(small)
Gender Minority Stress Mechanisms
 Internalized Stigma 14.0 (9.40) 12.3 (9.25) 0.73 0.48 −0.12
(negligible)
 Pride 14.7(6.69) 14.6 (8.16) −0.96 0.34 0.10
(negligible)
 Community Connectedness 12.2(4.78) 12.7 (4.41) 0.07 0.94 −0.01
(negligible)
 Anticipated Stigma 25.7(5.73) 19.9 (8.80) 3.53 0.002 −0.70
(medium)
Sig.
 Identity Concealment 13.9(4.26) 11.8 (3.04) 2.69 0.01 −0.43
(small)
Sig.
 Gender Identity Rumination 38.1 (10.1) 34.5 (7.59) 2.35 0.03 −0.39
(small)
Universal Mechanisms
 Emotion Dysregulation 2.90 (0.60) 2.61 (0.73) 2.42 0.02 −0.40
(small)
 Social Support 4.40 (1.03) 4.82 (1.23) −1.61 0.12 0.30
(small)
 Unassertiveness 72.0 (11.1) 67.3 (9.45) 2.61 0.02 −0.42
(small)
Sig.
 Rumination 13.9 (3.60) 12.4 (3.24) 2.07 0.05 −0.40
(small)

Note. Unless otherwise noted, mean scores are presented.

1

Wilcoxon matched pairs test to account for non-normal distribution

2

Statistical significance adjusted using the Benjamini-Hochberg method (1995)

Figure 2.

Figure 2.

Mental and behavioral health outcomes.

Only one participant reported taking PrEP, at follow-up. No participants reported being HIV-positive, but 16% (4/25) and 27% (6/22) reported not knowing their HIV status at baseline and 5-month follow-up, respectively. Additionally, 12% of participants reported engaging in any past-3-month HIV-transmission risk behavior at baseline. At follow-up, 4% reported past-3-month HIV-transmission risk behavior (p=0.25).

Minority stress mechanisms

Anticipated stigma (g=−0.70) and identity concealment (g=−0.43) significantly decreased between baseline and 5-month follow-up. Gender identity rumination showed a small decrease (g=−0.39). No significant changes were observed in other minority stress mechanisms (Figure 3).

Figure 3.

Figure 3.

Minority stress mechanisms.

Universal mechanisms

We found small effect sizes for changes in universal mechanisms. Unassertiveness (g=−0.42) decreased significantly. Social support increased (g=0.30), and emotion dysregulation (g=−0.40) and rumination (g=−0.40) both decreased between baseline and follow-up (Figure 4).

Figure 4.

Figure 4.

Universal mechanisms.

Treatment feasibility and acceptability

Session attendance was high: 96% of participants attended at least four sessions and 72% attended all 16 sessions. Acceptability came from exit interviews as detailed below by domain.

Relevance of treatment to personal goals

Most (8/10) found the treatment relevant, and many reached at least some of their goals. One participant stated: “Yes, overall, I did reach some of my goals. Most of them, only the one about the weight I didn’t reach.” (participant #1, transgender man, age 31) Another participant stated that “[My therapist] gave me some tips she knew about, and I used what she told me, and […] I became less of a procrastinator.” (participant #33, transgender woman, age 19)

Conversely, one participant found that the treatment did not align with their goal to increase positive emotions, perhaps consistent with the treatment’s focus on accepting emotions non-judgmentally without trying to control them. One participant stated that she met her goals without attributing the success to the treatment: “I can’t really associate my better state, like the alleviation of my symptoms, to the therapy itself but rather to the real tangible changes I made in the meantime in parallel with the therapy.” (participant #29, transgender woman, age 23)

Treatment impact on psychosocial health outcomes

Anxiety and depression.

Most (8/10) participants described that the treatment had a positive impact on their anxiety and/or depression, such as this participant:

The most important exercise […] was asking questions and getting to the bottom of my anxiety, the actual root of the problem […] such as, “If this happens, then what? If that happens, then what?” […] till we got to that root. It gave me this idea that it’s not actually that deep and it’s not that big of a problem and I can actually face it. (participant #18, transgender man, age 20)

Two participants perceived no impact of treatment on their anxiety or depression, while one participant felt that they had no significant depression symptoms to be addressed.

Alcohol and drug use.

Most (7/10) rarely or never used drugs or alcohol: “I never did do such things because I don’t like to ruin […] my life.” (participant #33, transgender woman, age 19)

Sexual behavior.

Only one participant described the treatment as relevant to their sexual behavior, stating that the treatment increased their comfort with sex by alleviating their gender dysphoria. However, four participants said that sexual risk behavior was not relevant to them.

Knowledge gained about minority stress from the treatment.

Most participants (7/10) had gained minority stress-related knowledge. For example, one participant stated: “I did realize that there were some […] mental health related issues, like anxiety maybe that stem from minority stress and from all the years that I’ve been, hanging onto things.” (participant #1, transgender man, age 31) Another participant described how they were able to see how challenges they faced were “interlinked” with their queer identity. (participant #5, transgender woman, age 21)

Treatment impact on gender-related experiences

Most participants (7/10) found the treatment to positively impact their gender-related experiences, such as a transgender woman who reclaimed their identity as a queer person.

Another participant described positive changes and increased hope because of the treatment:

[My therapist] changed my perspective about my transition because I never thought I could really do some things on my own because I never really had someone to tell me words like that. When I heard these things from her, somehow it changed my perspective and […] she gave me some hope I really needed. (participant #33, transgender woman, age 19)

In contrast, a few (3/10) said the treatment did not impact their view of their gender, with which they felt comfortable: “I don’t think I see differently my gender identity, my gender experience. I’m still the same. I still see myself the same way.” (participant #6, transgender man, age 21) Two participants expressed that they had experienced positive changes to how they viewed their gender but that they could not attribute the changes exclusively to the treatment.

Therapeutic alliance

Most participants (7/10) shared that they trusted their therapist. Only one participant had reservations, due to feelings of distrust of therapists in general: “I understand that it’s a therapist and even if the therapist liked me or not, she had to be warm and nice towards me. Knowing this, it’s hard to trust the therapist because that’s their job.” (participant #16, transgender man, age 24)

Nearly all (8/10) participants shared a positive evaluation of their therapist, explicitly stating that they “enjoyed the time spent with [the therapist].” Two participants shared that their therapist made them feel “safe” and “understood” during sessions:

I feel like she tried […] not to take things out of context. She would let me explain why I was feeling the way that I was feeling [and told me] what her interpretation was and would also ask me for feedback. (participant #5, transgender woman, age 21)

Pacing of treatment

Half of participants (5/10) found the treatment to be “a bit fast paced.” One participant felt that the sessions were too short: “[…] I expected them to be longer because I had […] more things to say but I was aware of […] the time and I tried to rush them out.” (participant #32, transgender woman, age 22) Two felt that the session frequency lent a comfortable pace. While one participant preferred more than 16 sessions, another felt that 16 sessions was adequate.

Videoconferencing experience

The majority of participants (6/10) felt comfortable meeting on Zoom. Participants shared that meeting on Zoom made treatment more accessible:

I struggle with talking to people that I don’t know that well in real life. I’ve always felt like there was this barrier with mental health professionals but having it over Zoom actually was helpful to me to be able to open up more. (participant #5, transgender woman, age 21)

Only two participants found meeting on Zoom to be stressful and less meaningful than in-person therapy. Half of participants (5/10) reported that communication went smoothly on Zoom. Only one participant shared that they had problems communicating on Zoom, specifically because of unfamiliarity with its functions such as turning their camera on.

Other overall reflections

Expectations not met.

Some participants (4/10) shared what they expected but did not get from the treatment, including one participant who had hoped for more of a focus on sexuality and mind-body connection: “I think the talk about the sexual life and the connection to our body because I think this is an important topic.” (participant #22, transgender man, age 22)

Similarly, participants (7/10) described topics they wanted but did not have a chance to talk about with their therapist. Most shared that they would have liked more space to vent: “Maybe it could have been—to have this, a small space to vent to go through […] the shit that had been happening in my week.” (participant #1, transgender man, age 31) Participants (4/10) also shared that the treatment did not help with certain issues but that they knew the treatment was not intended to address these, such as accessing care for medical gender affirmation.

Previous therapy experiences.

Most (7/10) shared that their prior experiences with therapy had been “very invalidating” and found the current treatment to be more validating: “It felt like she had an understanding of what my experience is basically which is not something that I have had when I did try to go to therapy in the past.” (participant #5, transgender woman, age 21)

Most and least helpful aspects.

All participants were able to pinpoint the most helpful aspects of the treatment, like the positive impact of seeing LGBTQ experiences throughout the treatment:

I thought that it was pretty helpful to see this narrative about someone who has my own specific experiences and my struggles because—I don’t know. I feel like a lot of things in regular cis-het society are not focused on queer people obviously. It’s nice to have these specific narratives be centered in the actual sessions. (participant #5, transgender woman, 21)

A few participants (4/10) also shared the conversations and moments that were least helpful, including specific exercises and discussion topics that did not feel relevant to them.

Interest and engagement.

Nearly all interviewed participants (9/10) described being interested in and engaged with the information presented in sessions, including one participant who could clearly recall a mindfulness exercise: “The mindfulness one I’ll probably never forget, and I think that one is stuck in my head.” (participant #30, transgender woman, age 19)

Therapist identity.

Some participants (3/10) noted that they had no preference for an LGBTQ therapist: “I’d rather have a very good therapist than someone from my community that’s not as talented, let’s say, at what they are doing.” (participant #1, transgender man, age 31). Still, two participants felt especially connected with their therapist who they perceived to be part of their community: “I think maybe opening up to another therapist that wasn’t part of the LGBTQ community would’ve been more difficult.” (participant #18, transgender man, age 20)

Overall suggestions.

Most participants (8/10) offered additional reflections on how the treatment could be improved. The most common suggestion was related to increased content flexibility:

Maybe for some people it’s a bit less about some of the objectives, some going towards a specific goal […] Maybe it’s that and a bit of venting because of all the things that come with being a trans person. (participant #1, transgender man, age 31)

Participant-generated themes

Two participants shared that the existence of this treatment had a positive impact on them because it gave them hope to see work being done to help their community:

That this program existed, and I was enrolled in it, and there were people around that tried to make this program, […] that gave their best to try to help us go through these issues and heal us […] was very helpful in keeping up hope and finding motivation (participant #29, transgender woman, age 23)

[…] people actually want to help the community, actually want to do this. There are therapists that actually are nice and empathetic and caring with trans people, and the world is not that gray and perhaps we are going in a better place. (participant #18, transgender man, age 20)

Discussion

The results of this study support the promise of LGBTQ-affirmative CBT for TGE individuals in a context of high stigma and few affirmative supports. While this was an open pilot and changes in outcomes cannot be definitively attributed to intervention exposure, participants who received LGBTQ-affirmative CBT experienced large improvements in mental health (e.g., depression symptoms and functional impairment associated with depression and anxiety) and smaller improvements in behavioral health (e.g., suicidality, hazardous drinking), which were not significant after adjusting for the false discovery rate. Several hypothesized mechanisms also improved, including identity-related minority stress mechanisms (e.g., anticipated stigma) and universal risk mechanisms (e.g., unassertiveness). Treatment acceptability was indicated via high session attendance and exit interviews revealing that the intervention educated participants about minority stress and affirmed their identities. Suggested areas of improvement included time for less structured conversations about immediate concerns outside of the CBT framework. These findings offer some of the first empirical support for LGBTQ-affirmative CBT for TGE adults outside of North America and suggest potential treatment mechanisms to test in future research, consistent with minority stress theory (Meyer, 2003) and its clinical extensions (Hatzenbuehler, 2009).

The reductions in depression symptoms and functional impairment associated with depression and anxiety in this trial cohere with trials of LGBTQ-affirmative CBT delivered to gender-diverse sexual minority women (Pachankis, McConocha, et al., 2020), where 40% of the sample identified as TGE and improvement in depression and anxiety severity and functional impairment represented the most robust findings. At the same time, we did not find effects for a sensitive measure of major depressive disorder diagnosis (i.e., CES-D; (Radloff, 1977), perhaps suggesting that in this context LGBTQ-affirmative CBT was associated with stronger impact on general depression symptoms and impairment compared to the higher threshold required for a major depressive disorder diagnosis. Effect sizes for hazardous drinking in the prior study (Pachankis, McConocha, et al., 2020) were stronger than found in the current trial, although participants in that previous study were recruited for their recent alcohol use. Effect sizes for suicidality found here are consistent with previous studies of LGBTQ-affirmative CBT (Pachankis, McConocha, et al., 2020) and other evidence-based approaches for sexual minority individuals (Pachankis, Williams, et al., 2020), calling for future research to target this outcome. Notably, no existing trials have enrolled participants based on suicidality, potentially explaining the relatively weak effects on this outcome, whereas this study excluded participants who were experiencing elevated suicidal ideation, which included two participants.

Effect sizes found here exceed those found by a meta-analysis of interventions for sexual minority men (Pantalone et al., 2020), which showed stronger effects for longer interventions delivered individually, versus in groups. The relatively strong results of the current study might be due to offering 16 psychologist-delivered sessions. Finally, participants reported low levels of HIV-transmission risk behavior, which likely explains the lack of effect for this outcome.

Consistent with minority stress theory (Meyer, 2003) and past trials (Pachankis, Soulliard, et al., 2023), receipt of LGBTQ-affirmative CBT was associated with small reductions in emotion dysregulation and unassertiveness in this study. As LGBTQ-affirmative CBT draws on the Unified Protocol’s mechanistic focus on emotion awareness and expression (Wilamowska et al., 2010), emotion dysregulation is a core hypothesized mechanism. The present intervention’s association with small a reduction in emotion dysregulation coheres with research on LGBTQ-affirmative CBT (Pachankis, McConocha, et al., 2020), although this reduction was not statistically significant in the context of the false discovery rate in the present study. Findings for unassertiveness also align with prior findings and provide a foundation for testing its mediating role in sufficiently powered trials.

As for minority stress mechanisms, participants in the present intervention experienced significant reductions in anticipated stigma and identity concealment, smaller reductions in identity-related rumination, and negligible shifts in internalized stigma, pride, and community connectedness. Similarly, research on LGBTQ-affirmative CBT delivered to other populations has found a significant impact on anticipated stigma (Pachankis, McConocha, et al., 2020). The current trial is the first to our knowledge to operationalize rumination as specific to one’s gender identity (Galupo & Bauerband, 2016) and the small effect for this mechanism found here calls for future clinical research that incorporates this particular experience. That identity concealment showed significant effects is unique to this research and perhaps attributable to the fact that identity concealment is generally high among TGE individuals in Romania (Bränström & Pachankis, 2021).

Conversely, null findings for the hypothesized mechanism of community connectedness might reflect challenges in building, or feeling connected to, a community of people with whom one shares a gender identity under structural conditions of normative concealment. Null findings for internalized stigma and its inverse, pride, are consistent with previous trials of LGBTQ-affirmative CBT that do not find these constructs to be a promising intervention mechanism, perhaps because of a lack of validity in its typical operationalizations (Pachankis, Hatzenbuehler, et al., 2023) and because they seem to operate more as treatment effect moderators (Yi et al., 2024) than mediators (Burger et al., 2024).

Participants deemed the acceptability of the intervention to be high and had more favorable impressions of this treatment compared to previously experienced ones. Notably, LGBTQ-affirmative CBT represented a rare supportive resource for TGE communities in Romania, whose presence itself conveyed affirmation.

Although HIV-transmission risk behavior was low in this sample, further research is needed to study the impact of LGBTQ-affirmative CBT on this outcome. However, given that only one participant was using PrEP and many did not know their HIV status, alongside the high global HIV rates among TGE populations (Becasen et al., 2019; Clark et al., 2017; Poteat et al., 2014), HIV rates might also be high among TGE people in Romania, although there are no national data. Efforts to document and address the local HIV epidemic among TGE individuals in Romania and neighboring countries should be prioritized.

This pilot trial offers a strong foundation for a future trial to test the efficacy of LGBTQ-affirmative CBT among a larger sample of TGE people in this region. At the same time, individual-level interventions must co-occur with structural interventions that address the upstream source of disproportionate health burden on TGE individuals (Cook et al., 2014). LGBTQ-affirmative CBT was not intended to modify structural inequities that adversely impact the psychosocial health of TGE people living in Romania (James et al., 2016). Still, individual-level affirmative supports may foster a self-affirmed population whose health and visibility can support structural change (Cook et al., 2014). Nonetheless, structural change itself represents the most just form of intervention as it places the onus for change on upstream drivers of ill health.

Limitations

The study presents several limitations. First, a trial with a larger sample, additional follow-ups over a longer period, and a control condition could permit attribution of improvements to the intervention. A larger sample size would also permit results to be stratified by various factors, including participants’ receipt of gender affirmation outside of this intervention (e.g., medical, legal), which has been shown to affect health and wellbeing (Lelutiu-Weinberger et al., 2020). Second, most scales have not been validated in Romania. Given the unique psychosocial context, aspects of these scales may need adaptation (e.g., assertiveness may be interpreted differently in Romania), which might explain low reliability of some measures (e.g., identity concealment). Additionally, although we took steps to highlight the distinct timeframe of each measure (e.g., using formatting emphasis for the time portion of each measure’s prompt), we do not know if the variable timeframe across measures (e.g., “past month” or “past year”) might have influenced results. Third, our use of AUDIT-C introduced potential temporal overlap between the baseline and 5-month follow-up period given that both points assessed hazardous drinking over the past year, which could have attenuated effects. Fourth, while session attendance was high, its validity as an indicator of intervention acceptability could have been undermined by the study incentive of $10 for completing each session, especially as most participants reported difficulty meeting basic needs. Still, exit interview feedback revealed generally positive experiences during the sessions, as another indicator of intervention acceptability. Fifth, future research should test the efficacy of integrating psychosocial interventions such as LGBTQ-affirmative CBT within medical sources of identity affirmation. Finally, future research is needed that tests the efficacy of interventions, including LGBTQ-affirmative CBT, for individuals currently experiencing elevated suicidal ideation given that the current study excluded such individuals given the scope of this study.

Conclusions

The present trial finds that LGBTQ-affirmative CBT is temporally associated with improvements in the mental and behavioral health of TGE living in contexts in a context of high structural stigma and normative lack of affirmative supports. Future trials may establish the comparative efficacy of this treatment, adjunctive supports that are necessary in high-stigma settings, and interventions that can simultaneously change upstream drivers of health inequities facing TGE individuals worldwide.

Highlights.

  • This study tested LGBTQ-affirmative CBT for transgender people in Romania.

  • LGBTQ-affirmative CBT was feasible and acceptable for this population.

  • Those who received LGBTQ-affirmative CBT reported improved mental health.

  • LGBTQ-affirmative CBT is promising for transgender people in high-stigma settings.

Acknowledgements:

We would like to thank Mr. Patrick Brăila and Mr. Sasha Ichim for their support in recruitment, Dr. Zachary Soulliard for providing supervision to study psychologists, and Ms. Anna Zavodszky for manuscript preparation support.

Funding:

This work was funded by the National Institute of Mental Health [grant number R01MH116829-S1].

Footnotes

Declaration of interest: John E. Pachankis receives royalties from Oxford University Press for books related to LGBTQ-affirmative mental health treatments.

Trial registration: Registered January 26, 2024 to ClinicalTrials.gov Identifier: NCT06229132.

Ethics approval and consent to participate: This research was conducted in accordance with the Declaration of Helsinki and relevant guidelines and regulations within the United States and Romania. This study was approved by the Columbia University Institutional Review Board (FWA0000263; protocol # AAAU2518, 09/27/2022), Yale University Institutional Review Board (FWA00002571; protocol # 2000024286, 11/06/2018), Rutgers University Institutional Review Board (FWA00003913; protocol # Pro2018000725, 08/04/2021), and the Bioethics Commission of the National Institute of Infectious Diseases in Bucharest Romania (FWA00013199, 06/14/2018). All participants provided informed consent to participate.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Austin A, Craig SL, & D’Souza SA (2018). An AFFIRMative cognitive behavioral intervention for transgender youth: Preliminary effectiveness. Professional Psychology: Research and Practice, 49(1), 1–8. [Google Scholar]
  2. Barlow DH, Farchione TJ, Bullis JR, Gallagher MW, Murray-Latin H, Sauer-Zavala S, Bentley KH, Thompson-Hollands J, Conklin LR, Boswell JF, Ametaj A, Carl JR, Boettcher HT, & Cassiello-Robbins C (2017). The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders: A randomized clinical trial. JAMA Psychiatry, 74(9), 875–884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bauerband LA, & Galupo MP (2014). The gender identity reflection and rumination scale: Development and psychometric evaluation. Journal of Counseling & Development, 92(2), 219–231. [Google Scholar]
  4. Becasen JS, Denard CL, Mullins MM, Higa DH, & Sipe TA (2019). Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. American Journal of Public Health, 109(1), e1–e8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Benjamini Y, & Hochberg Y (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289–300. [Google Scholar]
  6. Bentley KH, Gallagher MW, Carl JR, & Barlow DH (2014). Development and validation of the Overall Depression Severity and Impairment Scale. Psychological Assessment, 26(3), 815–830. [DOI] [PubMed] [Google Scholar]
  7. Bouman WP, Claes L, Brewin N, Crawford JR, Millet N, Fernandez-Aranda F, & Arcelus J (2017). Transgender and anxiety: A comparative study between transgender people and the general population. International Journal of Transgenderism, 18(1), 16–26. [Google Scholar]
  8. Bränström R, & Pachankis JE (2021). Country-level structural stigma, identity concealment, and day-to-day discrimination as determinants of transgender people’s life satisfaction. Social Psychiatry and Psychiatric Epidemiology, 56(9), 1537–1545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Budge SL, Adelson JL, & Howard KA (2013). Anxiety and depression in transgender individuals: The roles of transition status, loss, social support, and coping. Journal of Consulting and Clinical Psychology, 81(3), 545–557. [DOI] [PubMed] [Google Scholar]
  10. Budge SL, & Moradi B (2018). Attending to gender in psychotherapy: Understanding and incorporating systems of power. Journal of Clinical Psychology, 74(11), 2014–2027. [DOI] [PubMed] [Google Scholar]
  11. Burger J, Hollisaid N, Wang K, Safren SA, & Pachankis JE (2024). Toward a mechanistic understanding of LGBQ-affirmative cognitive-behavioral therapy: Testing treatment mediators in a randomized controlled trial with young gay and bisexual men. [Unpublished manuscript]. Department of Social and Behavioral Sciences, Yale University. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Burger J, & Pachankis JE (2024). State of the science: LGBTQ-affirmative psychotherapy. Behavior Therapy. Advance online publication. 10.1016/j.beth.2024.02.011 [DOI] [PubMed] [Google Scholar]
  13. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, & Project ACQI (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Archives of Internal Medicine, 158(16), 1789–1795. [DOI] [PubMed] [Google Scholar]
  14. Centers for Disease Control and Prevention. (n.d.). CDC issue brief: HIV and transgender communities. https://www.cdc.gov/hiv/pdf/policies/data/cdc-hiv-policy-issue-brief-transgender.pdf
  15. Chang SC, & Singh AA (2018). A clinician’s guide to gender-affirming care: Working with transgender and gender nonconforming clients. New Harbinger Publications. [Google Scholar]
  16. Clark H, Babu AS, Wiewel EW, Opoku J, & Crepaz N (2017). Diagnosed HIV infection in transgender adults and adolescents: results from the National HIV Surveillance System, 2009–2014. AIDS and Behavior, 21(9), 2774–2783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cook JE, Purdie-Vaughns V, Meyer IH, & Busch JT (2014). Intervening within and across levels: A multilevel approach to stigma and public health. Social Science & Medicine, 103, 101–109. [DOI] [PubMed] [Google Scholar]
  18. Craig SL, & Austin A (2016). The AFFIRM open pilot feasibility study: A brief affirmative cognitive behavioral coping skills group intervention for sexual and gender minority youth. Children and Youth Services Review, 64, 136–144. [Google Scholar]
  19. Derogatis LR, & Melisaratos N (1983). The Brief Symptom Inventory: An introductory report. Psychological Medicine, 13(3), 595–605. [PubMed] [Google Scholar]
  20. Elo S, & Kyngäs H (2008). The qualitative content analysis process. Journal of Advanced Nursing, 62(1), 107–115. [DOI] [PubMed] [Google Scholar]
  21. European Union Agency for Fundamental Rights. (2020). A long way to go for LGBTI equality. https://fra.europa.eu/sites/default/files/fra_uploads/fra-2020-lgbti-equality-1_en.pdf
  22. Farchione TJ, Long LJ, Spencer-Laitt D, Moreno J, & Barlow DH (2024). State of the Science: The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders. Behavior Therapy. Advance online publication. 10.1016/j.beth.2024.04.007 [DOI] [PubMed] [Google Scholar]
  23. Fontanari AMV, Vilanova F, Schneider MA, Chinazzo I, Soll BM, Schwarz K, Lobato MIR, & Brandelli Costa A (2020). Gender affirmation is associated with transgender and gender nonbinary youth mental health improvement. LGBT Health, 7(5), 237–247. [DOI] [PubMed] [Google Scholar]
  24. Galupo MP, & Bauerband L (2016). Sexual Orientation Reflection and Rumination Scale: Development and psychometric evaluation. Stigma and Health, 1(1), 44–58. [Google Scholar]
  25. Glick JL, Theall KP, Andrinopoulos KM, & Kendall C (2018). The role of discrimination in care postponement among trans-feminine individuals in the U.S. National Transgender Discrimination Survey. LGBT Health, 5(3), 171–179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gonzalez CA, Gallego JD, & Bockting WO (2017). Demographic characteristics, components of sexuality and gender, and minority stress and their associations to excessive alcohol, cannabis, and illicit (noncannabis) drug use among a large sample of transgender people in the United States. The Journal of Primary Prevention, 38(4), 419–445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hatzenbuehler ML (2009). How does sexual minority stigma “get under the skin”? A psychological mediation framework. Psychological Bulletin, 135(5), 707–730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hedges L, & Olkin I (1985). Statistical methods for meta-analysis. Academic Press. [Google Scholar]
  29. Heng A, Heal C, Banks J, & Preston R (2018). Transgender peoples’ experiences and perspectives about general healthcare: A systematic review. International Journal of Transgenderism, 19(4), 359–378. [Google Scholar]
  30. Hwang W-C. (2016). Culturally adapting evidence-based practices for ethnic minority and immigrant families. In Zane N, Bernal G, & Leon FTLg (Eds.), Evidence-based psychological practice with ethnic minorities: Culturally informed research and clinical strategies (pp. 289–308). American Psychological Association. 10.1037/14940-014 [DOI] [Google Scholar]
  31. James SE, Herman JL, Rankin S, Keisling M, Mottet L, & Anafi M (2016). The report of the 2015 U.S. Transgender Survey. National Center for Transgender Equality. https://transequality.org/sites/default/files/docs/usts/USTS-Full-Report-Dec17.pdf [Google Scholar]
  32. Keefe JR, Rodriguez-Seijas C, Jackson SD, Bränström R, Harkness A, Safren SA, Hatzenbuehler ML, & Pachankis JE (2023). Moderators of LGBQ-affirmative cognitive behavioral therapy: ESTEEM is especially effective among Black and Latino sexual minority men. Journal of Consulting and Clinical Psychology, 91(3), 150–164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lang AJ, Norman SB, Means‐Christensen A, & Stein MB (2009). Abbreviated brief symptom inventory for use as an anxiety and depression screening instrument in primary care. Depression and Anxiety, 26(6), 537–543. [DOI] [PubMed] [Google Scholar]
  34. Lelutiu-Weinberger C, English D, & Sandanapitchai P (2020). The roles of gender identity affirmation and discrimination in the resilience of transgender individuals in the U.S. Behavioral Medicine, 46(3–4), 175–188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Meyer IH (2003). Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. Psychological Bulletin, 129(5), 674–697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Miles MB, & Huberman M (1994). Qualitative data analysis: An expanded sourcebook. Sage Publications, Inc. [Google Scholar]
  37. Morrison SD, Wilson SC, & Smith JR (2017). Are we adequately preparing our trainees to care for transgender patients? Journal of Graduate Medical Education, 9(2), 258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Norman SB, Hami Cissell S, Means‐Christensen AJ, & Stein MB (2006). Development and validation of an overall anxiety severity and impairment scale (OASIS). Depression and Anxiety, 23(4), 245–249. [DOI] [PubMed] [Google Scholar]
  39. Pachankis JE (2015). A transdiagnostic minority stress treatment approach for gay and bisexual men’s syndemic health conditions. Archives of Sexual Behavior, 44(7), 1843–1860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pachankis JE (2018). The scientific pursuit of sexual and gender minority mental health treatments: Toward evidence-based affirmative practice. American Psychologist, 73(9), 1207–1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pachankis JE, Harkness A, Jackson S, & Safren SA (2022). Transdiagnostic LGBTQ-affirmative cognitive-behavioral therapy: Therapist guide. Oxford University Press. [Google Scholar]
  42. Pachankis JE, Harkness A, Maciejewski KR, Behari K, Clark KA, McConocha E, Winston R, Adeyinka O, Reynolds J, Bränström R, Esserman DA, Hatzenbuehler ML, & Safren SA (2022). LGBQ-affirmative cognitive-behavioral therapy for young gay and bisexual men’s mental and sexual health: A three-arm randomized controlled trial. Journal of Consulting and Clinical Psychology, 90(6), 459–477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pachankis JE, Hatzenbuehler ML, Klein DN, & Bränström R (2023). The role of shame in the sexual-orientation disparity in mental health: A prospective population-based study of multimodal emotional reactions to stigma. Clinical Psychological Science, 10.1177/21677026231177714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pachankis JE, McConocha EM, Clark KA, Wang K, Behari K, Fetzner BK, Brisbin CD, Scheer JR, & Lehavot K (2020). A transdiagnostic minority stress intervention for gender diverse sexual minority women’s depression, anxiety, and unhealthy alcohol use: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 88(7), 613–630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Pachankis JE, Soulliard ZA, Layland EK, Behari K, Seager van Dyk I, Eisenstadt BE, Chiaramonte D, Ljótsson B, Särnholm J & Bjureberg J (2023). Guided LGBTQ-affirmative internet cognitive-behavioral therapy for sexual minority youth’s mental health: A randomized controlled trial of a minority stress treatment approach. Behaviour Research and Therapy, 169, 104403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Pachankis JE, Williams SL, Behari K, Job S, McConocha EM, & Chaudoir SR (2020). Brief online interventions for LGBTQ young adult mental and behavioral health: A randomized controlled trial in a high-stigma, low-resource context. Journal of Consulting and Clinical Psychology, 88(5), 429–444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Pantalone DW, Nelson KM, Batchelder AW, Chiu C, Gunn HA, & Horvath KJ (2020). A systematic review and meta-analysis of combination behavioral interventions co-targeting psychosocial syndemics and HIV-related health behaviors for sexual minority men. The Journal of Sex Research, 57(6), 681–708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Pett MA (2015). Nonparametric statistics for health care research: Statistics for small samples and unusual distributions. Sage Publications. [Google Scholar]
  49. Popa M, Dragomir VD, Ionescu I, Brăila P, & Ion-Rotaru T (2020). Trans in Romania: Community, individual and legal experiences of transgender people in Romania. ACCEPT. https://transinromania.ro/wp-content/uploads/Trans-in-Romania_EN.pdf [Google Scholar]
  50. Poteat T, Reisner SL, & Radix A (2014). HIV epidemics among transgender women. Current Opinion in HIV and AIDS, 9(2), 168–173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Radloff LS (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. [Google Scholar]
  52. Rathus SA (1973). A 30-item schedule for assessing assertive behavior. Behavior Therapy, 4(3), 398–406. [Google Scholar]
  53. Reback CJ, Rünger D, & Fletcher JB (2017). Physical and/or sexual abuse are associated with negative health outcomes among transgender women of color living with HIV. Violence and Gender, 4(4), 130–136. [Google Scholar]
  54. Resnicow K, Baranowski T, Ahluwalia JS, & Braithwaite RL (1999). Cultural sensitivity in public health: defined and demystified. Ethnicity & Disease, 9(1), 10–21. [PubMed] [Google Scholar]
  55. Romanelli M, Lu W, & Lindsey MA (2018). Examining mechanisms and moderators of the relationship between discriminatory health care encounters and attempted suicide among US transgender help-seekers. Administration and Policy in Mental Health and Mental Health Services Research, 45(6), 831–849. [DOI] [PubMed] [Google Scholar]
  56. Scandurra C, Amodeo AL, Valerio P, Bochicchio V, & Frost DM (2017). Minority stress, resilience, and mental health: A study of Italian transgender people. Journal of Social Issues, 73(3), 563–585. [Google Scholar]
  57. Simes RJ (1986). An improved Bonferroni procedure for multiple tests of significance. Biometrika, 73(3), 751–754. [Google Scholar]
  58. Staples JM, Neilson EC, Bryan AE, & George WH (2018). The role of distal minority stress and internalized transnegativity in suicidal ideation and nonsuicidal self-injury among transgender adults. The Journal of Sex Research, 55(4–5), 591–603. [DOI] [PubMed] [Google Scholar]
  59. Statista. (2024, May 22). Share of people identifying as transgender, gender fluid, non-binary, or other ways worldwide as of 2023, by country. https://www.statista.com/statistics/1269778/gender-identity-worldwide-country/ [Google Scholar]
  60. Stroumsa D (2014). The State of Transgender Health Care: Policy, Law, and Medical Frameworks. American Journal of Public Health, 104(3), e31–e38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Testa RJ, Habarth J, Peta J, Balsam K, & Bockting W (2015). Development of the gender minority stress and resilience measure. Psychology of Sexual Orientation and Gender Diversity, 2(1), 65–77. [Google Scholar]
  62. Timmins L, Rimes KA, & Rahman Q (2017). Minority stressors and psychological distress in transgender individuals. Psychology of Sexual Orientation and Gender Diversity, 4(3), 328–340. [Google Scholar]
  63. Treynor W, Gonzalez R, & Nolen-Hoeksema S (2003). Rumination reconsidered: A psychometric analysis. Cognitive Therapy and Research, 27(3), 247–259. [Google Scholar]
  64. Valentine SE, & Shipherd JC (2018). A systematic review of social stress and mental health among transgender and gender non-conforming people in the United States. Clinical Psychology Review, 66, 24–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Van Spijker BAJ, Batterham PJ, Calear AL, Farrer L, Christensen H, Reynolds J, & Kerkhof AJFM (2014). The Suicidal Ideation Attributes Scale (SIDAS): Community‐based validation study of a new scale for the measurement of suicidal ideation. Suicide and Life‐Threatening Behavior, 44(4), 408–419. [DOI] [PubMed] [Google Scholar]
  66. Wilamowska ZA, Thompson‐Hollands J, Fairholme CP, Ellard KK, Farchione TJ, & Barlow DH (2010). Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders. Depression and Anxiety, 27(10), 882–890. [DOI] [PubMed] [Google Scholar]
  67. Yi M, Li X, Chiaramonte D, Sun S, Pan S, Eisenstadt BE, Ljótsson B, Hagaman A, & Pachankis JE (2024). Guided internet-based LGBTQ-affirmative cognitive-behavioral therapy: A randomized controlled trial among sexual minority men in China. [Unpublished manuscript]. Department of Social and Behavioral Sciences, Yale University. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Zimet GD, Powell SS, Farley GK, Werkman S, & Berkoff KA (1990). Psychometric characteristics of the multidimensional scale of perceived social support. Journal of Personality Assessment, 55(3–4), 610–617. [DOI] [PubMed] [Google Scholar]

RESOURCES